Conference Coverage
Trending on Pharm Tech
US Government Shutdown: Treating Regulatory Lapses as Predictable Operational Risks
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
Rare Disease Therapies: From Niche Experiment to Strategic Growth Engine
How a Government Shutdown Causes FDA Inspection Bottlenecks and Backlogs
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
Latest
Shorts
Drug Digest
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
Biopharma quality control is being revolutionized by advanced analytics and digital transformation through a synergy that boosts quality and scalability.
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
In this episode of Drug Digest, the discussion centers around the optimization of biopharmaceutical manufacturing and supply chain efficiency through the mastering of AI capabilities, data integration, and critical validation challenges.
Drug Digest: Small Molecules, APIs, and Excipients—Trends, Challenges, and Opportunities
In this exclusive Drug Digest video, Steve Barr from SK pharmteco and Prasad Raje from LGM Pharma explore how supply chain pressures, sustainability, and AI adoption are reshaping small molecule development and excipient use in pharma.
Drug Digest: Speed, Flexibility Top Large-Molecule Manufacturing Trends
In this exclusive Drug Digest video, Deepak Bahl from Roquette and Jagruti Patel from Lonza look at strategies for accelerating early-stage development while reducing risk, approaches to speeding up timelines for complex formats without sacrificing quality, and maintaining a flexible CMC process that ensures quality.
Drug Digest: Patient Preference Drives Solid Dosage Trends
In this exclusive Drug Digest video, Adi Kaushal from Lonza summarizes the current state of the oral solid dosage market, identifies the main challenges to drug developers, explains how CDMOs are leveraging expert techniques to improve OSD bioavailability, and looks into the future of advancements in drug delivery.
Drug Digest: Keeping Pace with Progressive Technologies in Biopharma Development
This episode of Drug Digest will discuss where the significant bottlenecks are in the development and manufacturing of new molecules resulting from progressive technologies, such as AI and ML, and how best to approach these challenges.
Drug Digest: Strategic Partnerships
In this exclusive Drug Digest video interview John McQuaid from Almac Pharma Services and Sridevi Khambhampaty from Shilpa Biologics delve into the evolution of the bio/pharma outsourcing market and look at how service-providers’ strategies have adapted to meet demand.
Drug Digest: Advances in Small-Molecule Manufacturing
In this exclusive Drug Digest video interview Anil Kane from Thermo Fisher Scientific will be tackling the topic of advances in small-molecule manufacturing and several other experts will provide brief commentaries on associated topics.
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
In this episode of Drug Digest, industry experts discuss their experiences in dealing with the challenges of developing and manufacturing next-generation biotherapeutics as well as triumphs that move the industry as a whole forward.
Drug Digest: Focusing on Solid Dosage Trends and Demand
In this exclusive Drug Digest video interview an industry expert discusses key trends impacting solid dosage drug development and manufacturing.
Videos
Pharmaceutical Technology Is Now PharmTech: A Sharper Name for a Smarter Industry
Welcome to the renewed PharmTech.
Behind the Headlines Episode 28
Navigating FDA Shakeups and Obesity Drug Wars
Ask the Expert
Audits, Inspections, and CDMOs
Drug Digest December 2025
Closing the Gap in Modern Process Control and Automation for QC/QA
A “Plan, Prevent, Prove” Approach
How It Helps Avoid Facility and Equipment Problems
All News
With a potential US government shutdown looming, Megha Sinha, Kamet Consulting, says to treat FDA disruptions as predictable risks by protecting milestones and early readiness.
In part one of this four-part series regarding rare diseases, the author explores how rare disease treatment development evolved from a niche area to a cornerstone of biopharma growth.
With a potential US government shutdown looming, Megha Sinha, Kamet Consulting, discusses the impacts on pharma manufacturing and development.
Visit PharmTech.com for upcoming coverage of the International Day of Women and Girls in Science on February 11.
WuXi Biologics and HanchorBio partner to accelerate multi-functional fusion protein translation via end-to-end CMC and GMP services.
Laine Mello, director of Marketin, Ecolab, details how AI, continuous manufacturing, and Pharma 4.0 drive bioprocessing efficiency and cost savings.
US WHO withdrawal triggers pharma regulatory and supply chain risks while impacting global R&D collaborations.
Raj Puri, CCO, Argonaut Manufactoring, provides key insight on navigating tariffs, supply redundancy, and the risks of compressed timelines.
The European Commission has approved GSK’s adjuvanted recombinant respiratory syncytial virus vaccine, Arexvy, for use in adults aged 18 years and older.
Mirum Pharmaceuticals acquires Bluejay Therapeutics, adding a Phase 3 antibody for chronic hepatitis delta virus to its pipeline.
We're embracing who we are, magnifying engagement for scientists and innovators, personifying expertise for science-driven insights, and taking our brand and your business to the next level. Welcome to the renewed PharmTech.
In a 2026 industry outlook interview, Laine Mello, Ecolab Life Sciences, explains how next-gen therapies, digitalization, and partnerships drive pharma agility.
This week's coverage discusses pharma advances in sustainable packaging and digital standards amid trade risks from Greenland tariffs and falling workforce morale
In a 2026 industry outlook interview, Laine Mello, Ecolab Life Sciences, details how AI and Pharma 4.0 speed up discovery and production while navigating industry hurdles
The draft, focused on quality information for medicinal product registration applications, was released to allow for public comments through March 23, 2026.
The United States Pharmacopeia is developing digital standards for digital-first workflows and regulatory confidence.
Even the threat of Greenland-related tariffs rattled drug supply chains and uncovered industry vulnerabilities to instability.
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs company, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, discuss how involving procurement early on in drug development can ensure a quality product.
At the Pharmapack Europe 2026 awards ceremony, Pharmapack announced it is expanding the event to Singapore in November 2026. This year’s award winners were also announced.
ACG’s new SuperPod reduces blister size and boosts efficiency and sustainability for moisture-sensitive drug products.
PharmTech spoke with Dexter Tjoa, CEO of Tjoapack, about how outside pressures are influencing supply chain and packaging decisions.
The three firms offer a pre-verified platform for large-volume subcutaneous delivery of biologics to enable home self-administration.
The half-day workshop will explore regulatory compliance and environmental sustainability.
Proteasome-targeting therapies may eliminate disease-causing proteins in a broad range of diseases.
PharmTech spoke with Dexter Tjoa, CEO of Tjoapack, about the past year and which trends might influence 2026 packaging decisions.
West has launched Synchrony S1, a prefillable syringe system to simplify biologic delivery and combination product needs.
A comparison of 2024 and 2025 bio/pharma employment survey results indicates that industry professionals face eroding security, polarized satisfaction, and rising attrition risk.
Industry experts discuss the standout packaging trends from 2025 that will influence the industry’s future.
Syngene has extended its Bristol Myers Squibb alliance to 2035 and invests in automation to accelerate integrated drug development and manufacturing.
Sharp increases European injectable assembly and secondary packaging capacity to support the rising demand for pre-filled syringes and autoinjectors.
Contract development and manufacturing organizations offer specialized services to help sponsor companies develop drug products that better serve the unique needs of patients.
Ensuring quality, sterility, and regulatory compliance are essential when choosing analytical methods.
The week’s coverage discusses leveraging agentic AI, sustainability, and resilient supply chains to transform global drug development and safety.